Clinical trial • Phase IV • Dermatology

Clinical trial in Vitiligo

Phase IV trial for Vitiligo. 140 participants.

Overview

Trial Therapeutic Area
Dermatology
Trial Disease
Vitiligo
Trial Stage
Phase IV

Key dates

Initial CTIS Submission Date
10-11-2023
First CTIS Authorization Date
08-03-2024

Trial design

Phase IV trial across 5 sites in France.

Target Sample Size
140

Recruitment

Planned Sample Size
140
Recruitment Window Months
30

Geography

Total Number Of Sites
5
Total Number Of Participants
140

France

Earliest CTIS Part Ii Submission Date
26-02-2024
Latest Decision Or Authorization Date
02-09-2025
Processing Time Days
557
Number Of Sites
5
Number Of Participants
140

Sites

Site Name
Centre Hospitalier Universitaire De Nice
Department Name
Dermatologie
Principal Investigator Name
Passeron Thierry
Principal Investigator Email
passeron.t@chu-nice.fr
Contact Person Name
Passeron Thierry
Contact Person Email
passeron.t@chu-nice.fr
Site Name
Centre Hospitalier Universitaire De Bordeaux
Department Name
Dermatologie
Principal Investigator Name
Seneschal Julien
Principal Investigator Email
julien.seneschal@chu-bordeaux.fr
Contact Person Name
Seneschal Julien
Site Name
Assistance Publique Hopitaux De Paris
Department Name
Dermatologie
Principal Investigator Name
Ezzedine Khaled
Principal Investigator Email
khaled.ezzedine@aphp.fr
Contact Person Name
Ezzedine Khaled
Contact Person Email
khaled.ezzedine@aphp.fr
Site Name
Hospices Civils De Lyon
Department Name
Dermatologie
Principal Investigator Name
Lesort Cécile
Principal Investigator Email
cecile.lesort@chu-lyon.fr
Contact Person Name
Lesort Cécile
Contact Person Email
cecile.lesort@chu-lyon.fr
Site Name
Centre Hospitalier Universitaire De Lille
Department Name
Dermatologie
Principal Investigator Name
MORTIER Laurent
Principal Investigator Email
laurent.mortier@chru-lille.fr
Contact Person Name
MORTIER Laurent
Contact Person Email
laurent.mortier@chru-lille.fr

Sponsor

Primary sponsor

Full Name
Centre Hospitalier Universitaire De Nice
Organisation Type
Hospital/Clinic/Other health care facility
Country Of Registered Address
France

Related trials

Other published trials that may interest you.